Impact of implantable cardioverter defibrillators on survival and recurrent hospitalization in advanced heart failure

American Heart Journal

Volumn 150, Issue 5, 2005, Pages 955-960

  Nazarian, Saman ^a   Maisel, William H ^b   Miles, J Shawn ^a   Tsang, Sui ^b   Stevenson, Lynne W ^b   Stevenson, William G ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATOR; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART VENTRICLE ARRHYTHMIA; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; QRS COMPLEX; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME; SYMPTOM; SYNCOPE;

DEFIBRILLATORS, IMPLANTABLE; DISEASE PROGRESSION; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 27744445170     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.01.012     Document Type: Article

References (14)

1. W.G. Stevenson, and L.W. Stevenson Prevention of sudden death in heart failure J Cardiovasc Electrophysiol 12 2001 112 114
2. M.O. Sweeney Sudden death in heart failure associated with reduced left ventricular function: substrates, mechanisms, and evidence-based management. Part I Pacing Clin Electrophysiol 24 2001 871 888
3. V. Essebag, and M.J. Eisenberg Expanding indications for defibrillators after myocardial infarction: risk stratification and cost effectiveness Card Electrophysiol Rev 7 2003 43 48
4. A.J. Moss, W. Zareba, and W.J. Hall Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
5. G.H. Bardy, K.L. Lee, and D.B. Mark Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
6. B.L. Wilkoff, J.R. Cook, and A.E. Epstein Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial JAMA 288 2002 3115 3123
7. S.E. Sandner, G. Wieselthaler, and A. Zuckermann Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation Circulation 104 12 Suppl 1 2001 I171 I176
8. M.R. Bristow, L.A. Saxon, and J. Boehmer Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
9. M.O. Sweeney, J.N. Ruskin, and H. Garan Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation Circulation 92 1995 3273 3281
10. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias N Engl J Med 337 1997 1576 1583
11. S.J. Connolly, M. Gent, and R.S. Roberts Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone Circulation 101 2000 1297 1302
12. A.E. Buxton, K.L. Lee, and J.D. Fisher A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators N Engl J Med 341 1999 1882 1890
13. S.J. Connolly, A.P. Hallstrom, and R. Cappato Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study Eur Heart J 21 2000 2071 2078
14. G.C. Fonarow, Z. Feliciano, and N.G. Boyle Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable cardioverter-defibrillator Am J Cardiol 85 2000 981 985